Quantcast
Home / Opinion / Commentary / Reforming FDA, not price control, is path to cheaper drugs

Reforming FDA, not price control, is path to cheaper drugs

It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

In this Aug. 9, 2011, photo, the sun emits a gigantic burst of radiation. (Photo courtesy of NASA)

Solar group: Prop. 127 is ‘reckless, restrictive and inflexible’

The Distributed Energy Resource Alliance (DERA), composed of solar industry companies, professionals and educators, urges Arizonans to vote no on Proposition 127.